How Much Does Chemotherapy for pancreatic cancer Cost in Republic of Korea?
Chemotherapy for pancreatic cancer in the Republic of Korea typically costs from $6,500 to $12,500. Prices vary based on the specific drug regimen, hospital tier, and the number of cycles required. Patients save approximately 66% compared to the US, where costs average $28,000. Treatment usually includes medications, specialist consultations, and laboratory tests.
- Regimen type: Advanced protocols like FOLFIRINOX or gemcitabine-based combinations typically increase the base cost.
- Hospital tier: Prices in major Seoul-based medical centers are often 15-20% higher than regional hospitals.
- Supportive care: Hospitalization fees and management of treatment side effects are usually billed as additional costs.
- Diagnostic monitoring: Regular CT or MRI scans to track tumor response impact the total treatment budget.
Bookimed Expert Insight: Choosing a Seoul-based digital hospital provides high-tech care without the premium US price tag. Seoul National University Hospital (SNUH) and Severance Hospital are top-rated by Newsweek. They offer survival rates that often exceed international averages. Severance Hospital partners with MD Anderson, ensuring access to global oncology standards. Asan Medical Center provides free airport transfers and personal coordinators for international patients. This adds significant value to their oncology packages.
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Chemotherapy for pancreatic cancer | ≈ $6,500 | from $1,500 | ≈ $9,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for pancreatic cancer upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for pancreatic cancer and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for pancreatic cancer journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Chemotherapy for pancreatic cancer Clinics in Republic of Korea: 6 Verified Options and Prices
Chemotherapy for pancreatic cancer Overview in Republic of Korea
- Chemotherapy - from $1,900This therapy treats cancer by using drugs to destroy cancer cells and prevent their growth.
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - from $18,000The operation heats chemotherapy drugs and applies them directly inside the belly to kill hidden cancer cells.
- Chemotherapy for liver cancer - from $3,000This therapy targets and kills cancer cells in the liver, using drugs given by mouth or injection.
- Chemotherapy for lung cancer - from $1,500This therapy utilizes drugs to kill lung cancer cells, often given via injection or oral tablet, enhancing survival rates.
- Chemotherapy for breast cancer - from $3,000This therapy targets and destroys breast cancer cells, using powerful drugs, enhancing survival and recovery rates.
Day 1
- Arrive at the clinic.
- Meet with the oncologist for consultation.
- Complete blood tests and scans.
- Discuss chemotherapy plan with oncologist.
Day 2
- Begin first chemotherapy session.
- Chemotherapy is administered intravenously.
- Each session lasts for about 2-3 hours.
- No anesthesia is required for chemotherapy.
Day 3-5
- Rest and recuperate at home.
- Manage symptoms and side effects of chemotherapy.
Week 2
- Return to clinic for second chemotherapy session.
- Monitor progress and adjust treatment plan if necessary.
Weeks 3-6
- Continue chemotherapy sessions on a weekly basis.
- Manage side effects and maintain a healthy diet.
Week 7
- Evaluate treatment progress with oncologist.
- Additional scans and tests may be required.
Week 8-12
- Continue weekly chemotherapy sessions.
- Manage side effects and maintain physical health.
Weeks 12-16
- Gradual return to normal activities is possible.
- Continue to manage side effects and diet.
Week 17 onwards
- End of chemotherapy sessions.
- Follow-up with oncologist for regular check-ups.
- Gradually return to work and other activities.
Please note that each patient"s journey is unique and the timeline may vary based on the patient"s response to treatment.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Doctors
View all Doctors
Dong Hyeon Lee
Dr. Dong Hyeon Lee is a hematologist-oncologist at Ewha Womans University Medical Center in Seoul. He specializes in bone marrow transplantation, including alternate donor and mismatched transplants. Dr. Lee treats colon cancer, myeloma, and lymphoma. He is a member of multiple professional oncology societies.
- Holds a Ph.D. from Sungkyunkwan University College of Medicine.
- Performs bone marrow transplants for complex hematological conditions.
- Authored over 10 peer-reviewed research papers in oncology.
- Works at a JCI-accredited hospital ranked among the world's best by Newsweek.

Lee, Han-Byoel
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Chemotherapy for pancreatic cancer in Republic of Korea
What are the standard chemotherapy regimens currently used in South Korea for pancreatic cancer?
Standard chemotherapy for pancreatic cancer in South Korea primarily utilizes FOLFIRINOX and Gemcitabine plus Nab-paclitaxel (Abraxane) as first-line treatments. These regimens follow the Korean Clinical Practice Guidelines and Pan-Asian adapted ESMO standards. Selection depends on disease stage, genetic markers like BRCA, and patient performance status.
- First-line combination: FOLFIRINOX uses 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin for metastatic cases.
- Tolerability preference: Gemcitabine plus Nab-paclitaxel is often preferred for its perceived better tolerability.
- Oral alternatives: S-1 (Tegafur/Gimeracil/Oteracil) serves as a convenient daily oral therapy with lower toxicity.
- Advanced delivery: Hyperthermic intraperitoneal chemotherapy (HIPEC) is frequently combined with surgery at specialized centers.
Bookimed Expert Insight: South Korean oncology centers like Asan Medical Center and Severance Hospital often prioritize rapid genetic testing. This allows surgeons to tailor treatments, such as using PARP inhibitors for BRCA mutations, much faster than in Western facilities. This efficiency, combined with high-volume digital systems at Seoul National University Hospital, significantly reduces the time from diagnosis to the first infusion.
Patient Consensus: Patients report that tracking neuropathy early is essential for dose modifications. Many find that South Korean clinical trials offer much faster enrollment than in the US.
Is chemotherapy necessary for Stage 4 pancreatic cancer?
Chemotherapy is the standard medical recommendation for stage 4 pancreatic cancer in the Republic of Korea. While not curative for metastatic disease, it remains the primary tool for life extension, symptom management, and slowing cancer progression in JCI-accredited Seoul facilities.
- Survival outcomes: Systemic treatment can extend median survival to 11 months versus 3–6 months without.
- Primary protocols: Korean specialists typically utilize FOLFIRINOX or Gemcitabine-Abraxane combinations based on patient fitness.
- Palliative benefits: Direct tumor shrinkage relieves physical pressure and pain from metastases in distant organs.
- Treatment eligibility: Doctors may defer chemotherapy if poor performance status makes side effects outweigh benefits.
- Alternative pathways: Patients may access advanced clinical trials or proton therapy at centers like Severance.
Bookimed Expert Insight: Major Korean centers like Asan Medical Center and SNUH handle massive patient volumes, often seeing over 10,000 outpatients daily. This high frequency means oncology teams have deep experience managing the severe side effects of aggressive FOLFIRINOX regimens. Choosing these high-volume digital hospitals may reduce the risk of dosing errors and improve symptom monitoring.
Patient Consensus: Many patients face a difficult choice between quality and quantity of life due to neuropathy. While Korean doctors often recommend immediate treatment, the availability of comprehensive palliative care provides a supportive alternative.
Which hospitals in Korea are considered top-tier for pancreatic cancer care?
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital are the top-tier institutions for pancreatic cancer in South Korea. These facilities lead globally in oncology, offering advanced robotic surgery, specialized chemotherapy protocols like FOLFIRINOX, and multidisciplinary teams for complex cases.
- Samsung Medical Center: Ranked 3rd globally for oncology with exclusive Da Vinci Xi robotic systems.
- Asan Medical Center: South Korea largest hospital performing high volumes of complex pancreatic surgeries daily.
- SNU Hospital: Maintains world-class safety records while performing over 500 pancreatic surgeries annually.
- Severance Hospital: First JCI-accredited cancer center in Korea specializing in robotic-assisted pancreatic procedures.
- SNU Bundang Hospital: Uses the digital BESTcare system to maximize chemotherapy safety and clinical precision.
Bookimed Expert Insight: While all Big 5 hospitals are excellent, Asan Medical Center and Samsung Medical Center show higher popularity for aggressive stage 3 or 4 cases. These centers provide unique access to nanoliposomal irinotecan protocols and clinical trials not always available at smaller regional facilities.
Patient Consensus: Patients emphasize contacting international departments early to verify eligibility for specialized clinical trials. Many suggest budgeting for Seoul-based travel, as the survival outcomes at these top-tier centers justify the additional logistics.
Are there innovative or alternative treatments available for pancreatic cancer in Korea?
South Korea offers cutting-edge pancreatic cancer treatments including Natural Killer (NK) cell immunotherapy, proton beam therapy, and genomic-driven precision medicine. Major Seoul centers like Severance Hospital and Seoul National University Hospital integrate these with advanced robotic surgery and specialized Korean Traditional Medicine to improve survival outcomes.
- NK cell therapy: Experimental immunotherapy multiplies a patient's immune cells to target resistant tumors.
- Proton beam therapy: Precise radiation targets pancreatic tumors while sparing critical surrounding digestive organs.
- Genomic profiling: Standard molecular testing at SNUH matches specific tumor mutations to targeted drugs.
- HIFU technology: Focused ultrasound disrupts tumor protective layers to enhance chemotherapy drug penetration.
Bookimed Expert Insight: While many seek basic chemotherapy, South Korea's real advantage is the high volume of clinical trials. Centers like Asan Medical Center handle over 65,000 operations annually. This massive patient flow allows clinics to offer specific immunotherapy combinations often unavailable in other countries.
Patient Consensus: Patients value the aggressive surgical approach for locally advanced cases. Many recommend bringing imaging in DICOM format to avoid repeated testing costs during the initial assessment.
















